|
NDUFS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60720003972159E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.7428999899447E-09 |
| Normal-vs-Stage2 |
1.492240E-02 |
| Normal-vs-Stage3 |
1.6728399999999E-05 |
| Normal-vs-Stage4 |
2.94070000017577E-07 |
| Stage1-vs-Stage2 |
3.903600E-01 |
| Stage1-vs-Stage3 |
7.600000E-01 |
| Stage1-vs-Stage4 |
8.517800E-02 |
| Stage2-vs-Stage3 |
5.879000E-01 |
| Stage2-vs-Stage4 |
9.863500E-02 |
| Stage3-vs-Stage4 |
9.061700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14080001001327E-09 |
| Normal-vs-AfricanAmerican |
1.02670000001748E-06 |
| Normal-vs-Asian |
2.082400E-03 |
| Caucasian-vs-AfricanAmerican |
6.905000E-01 |
| Caucasian-vs-Asian |
8.230800E-01 |
| AfricanAmerican-vs-Asian |
7.352200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55479962238303E-10 |
| Normal-vs-Female |
1.816470E-04 |
| Male-vs-Female |
3.594100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.48999999999234E-05 |
| Normal-vs-Extreme_Weight |
7.39730499077496E-12 |
| Normal-vs-Obese |
3.84270000264308E-08 |
| Normal-vs-Extreme_Obese |
4.363200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.862570E-01 |
| Normal_Weight-vs-Obese |
7.903200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.198400E-01 |
| Extreme_Weight-vs-Obese |
1.352030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.098960E-01 |
| Obese-vs-Extreme_Obese |
2.283600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92038999999866E-05 |
| Normal-vs-Age(41-60Yrs) |
3.12280001857346E-09 |
| Normal-vs-Age(61-80Yrs) |
8.9145000270463E-09 |
| Normal-vs-Age(81-100Yrs) |
5.361100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.390000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.192000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.881400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.003400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.953600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.502400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.3673951687897E-11 |
| Normal-VS-Type2 PRCC |
2.656100E-03 |
| Normal-VS-KIRP CIMP |
1.88140000001447E-06 |
| Normal-VS-Unclassified PRCC |
5.014000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.638900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.005400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.384100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.130340E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.429400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.107230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04569999992421E-07 |
| Normal-vs-N1 |
7.25170000048792E-07 |
| Normal-vs-N2 |
3.361300E-04 |
| N0-vs-N1 |
8.046800E-01 |
| N0-vs-N2 |
5.231600E-01 |
| N1-vs-N2 |
5.548600E-01 |
|
|
